Reishi Mushroom: Complete Health Research Profile

Reishi mushroom (Ganoderma lucidum, also called lingzhi) is a woody, reddish-brown fungus used for centuries in traditional Chinese medicine. Modern human research on reishi is still limited: most positive findings come from lab and animal studies, while controlled human trials show smaller, mixed effects on immune activity, fatigue, and sleep. No U.S. regulatory agency has approved reishi to treat, prevent, or cure any disease.

Urgent Safety Information First

Before considering any reishi product, know these risk points:

Bleeding risk: Reishi may slow blood clotting. Combining it with blood thinners or antiplatelet medication can increase bruising and bleeding risk.
Surgery: High doses may raise bleeding risk during and after surgery. Guidance suggests stopping reishi at least two weeks before a scheduled procedure.
Blood pressure and blood sugar medications: Reishi may lower blood pressure and blood sugar. Taking it alongside antihypertensive or antidiabetic drugs may cause levels to drop too low.
Liver concern: Rare case reports describe liver injury linked to reishi products, particularly powdered whole-mushroom forms rather than traditional water extracts.
Immunosuppressant medications: Because reishi may stimulate immune activity, it could work against drugs that suppress the immune system, such as those used after organ transplant.

Anyone on these medications, anyone with liver disease, and anyone scheduled for surgery should talk with a clinician before using reishi.

Bioactive Compounds: Triterpenes and Beta-Glucans

Reishi contains hundreds of biologically active compounds. Research has focused mainly on two groups:

Triterpenes (ganoderic acids): Studied in lab and animal models for antioxidant, anti-inflammatory, and antitumor activity. These effects are largely preclinical and have not been confirmed at the same scale in humans.
Beta-glucans (polysaccharides): A type of complex carbohydrate researchers believe drives many of reishi’s immune-related effects. Clinical studies suggest reishi beta-glucans can increase certain immune cell counts in humans, though the clinical meaning of these changes is still being studied.

Extraction method affects which compounds end up in a product. Water-based extraction concentrates beta-glucans, while alcohol-based extraction concentrates triterpenes. Whole fruiting-body powder is different again, since it isn’t concentrated by either process. A product’s label does not always specify which method was used.

Human Clinical Evidence: Immune Function

A randomized, placebo-controlled trial in healthy adults found that a Ganoderma-derived beta-glucan supplement, taken daily for 84 days, was linked to increases in several immune cell markers, including T-lymphocyte subsets and natural killer cell counts, compared with placebo. This is one of the more direct human signals for reishi’s immune effects, though it measured cell counts rather than actual infection outcomes.

In cancer research, a Cochrane systematic review pooling five randomized controlled trials (373 participants) found that people who added Ganoderma lucidum extract to chemotherapy or radiotherapy were more likely to respond to that conventional treatment than those who did not, and the extract was linked to increases in certain immune cell percentages. The review found no significant effect on tumor shrinkage when reishi was used alone, and the authors flagged small trial sizes, a Chinese-only participant pool, and quality concerns as limitations. Minor side effects including nausea and insomnia were reported in some trials. This evidence describes reishi as a possible complement alongside standard cancer treatment under medical supervision, not a standalone therapy.

The National Cancer Institute notes that laboratory and animal research has tested reishi’s effects on tumors, and that a small open-label trial in China gave a reishi-based product to patients with advanced lung cancer already receiving chemotherapy or radiation, with findings suggesting the addition may help support immune function. The NCI is explicit that the FDA has not approved reishi to treat cancer or any other medical condition.

Human Clinical Evidence: Sleep and Fatigue

Sleep-specific reishi research in humans is preliminary and often studies reishi as part of a mushroom blend rather than alone, which makes it hard to isolate reishi’s individual effect.

A 2026 randomized, double-blind, placebo-controlled trial testing a mushroom blend supplement (including reishi) measured sleep quality using the Pittsburgh Sleep Quality Index alongside fatigue and anxiety scales, reporting improvements on anxiety measures. Because reishi was combined with other mushroom species, its individual contribution to sleep outcomes cannot be separated out from this design.
A registered randomized, waitlist-controlled trial is currently examining a lingzhi-containing supplement for chronic fatigue and post-COVID-19 fatigue, with sleep quality as a secondary measure. Results were not yet available as of this writing.
A crossover trial of reishi in men with Gulf War illness examined pain and fatigue outcomes and did not focus specifically on sleep quality as a primary measure.

Bottom line: reishi’s traditional reputation for supporting rest is not yet backed by strong, reishi-only human sleep trials. Readers looking for evidence-graded sleep research should treat this area as preliminary.

Preclinical and Mechanistic Findings (Not Yet Confirmed in Humans)

These findings come from cell-culture or animal studies and describe possible mechanisms, not confirmed human outcomes:

Reishi extracts have shown anti-inflammatory activity in animal and cell models, including reduced inflammatory markers in mouse studies.
Triterpene compounds have shown antitumor and antiviral activity in laboratory settings.
Animal and in vitro research has explored hepatoprotective (liver-protecting) and renoprotective (kidney-protecting) properties, findings that stand in tension with the rare human case reports of reishi-linked liver injury described above, a reminder that lab results do not always predict real-world human safety.

Evidence Checklist by Proposed Benefit

Immune cell modulation: Strongest evidence type is a human randomized controlled trial in healthy adults. It shows increases in certain immune cell counts over 84 days versus placebo.
Adjunct to cancer treatment: Strongest evidence type is a Cochrane review of five human randomized controlled trials. It shows a better response to chemotherapy or radiotherapy when reishi is added, no effect on tumor size when used alone, and the trials were small and based in China.
Fatigue support: Strongest evidence type is human randomized controlled trials that are preliminary or still ongoing. Reishi is often tested as part of a blend, not alone.
Sleep quality: Strongest evidence type is a human randomized controlled trial testing a blend, not reishi alone. This benefit is not yet established for reishi specifically.
Anti-inflammatory and antitumor mechanisms: Strongest evidence type is animal and in vitro research. This shows a promising mechanism, not a confirmed clinical benefit.

Extra-Caution Groups

People taking anticoagulant or antiplatelet medications
People taking antihypertensive or antidiabetic medications
People scheduled for surgery in the next several weeks
People with liver disease or a history of liver injury
People taking immunosuppressant medications
Pregnant or breastfeeding individuals, due to a lack of safety research in this population

Where the Evidence Runs Out

Reishi research has real gaps readers should know about:

Most human trials are small, short in duration, and conducted in China or other parts of Asia, which limits how well findings apply to other populations.
Many trials study reishi within a blend of other mushrooms or herbs, making it hard to isolate reishi’s specific contribution.
Products vary widely in form (fruiting body, mycelium, spore, extract) and extraction method, and these differences are not standardized across the research base or consistently disclosed on labels.
Long-term safety data in healthy populations, and safety data in pregnancy, are lacking.

Frequently Asked Questions

Is reishi mushroom safe to take every day?

Short-term use has been studied in some clinical trials, but long-term daily safety data in healthy people is limited, and rare cases of liver injury have been reported. Anyone considering daily use should check with a clinician first, especially if they take other medications.

Can reishi cure or prevent cancer?

No. Laboratory and small clinical studies suggest reishi extract may support a better response to standard chemotherapy or radiotherapy when used alongside it, but the evidence does not show it shrinks tumors on its own, and the FDA has not approved it to treat any cancer. Decisions about cancer treatment should always involve an oncologist.

Does reishi help you sleep?

Reishi has a long traditional reputation for promoting rest, but reishi-specific human sleep trials are limited, and most available data come from mushroom blends rather than reishi alone. This is considered preliminary evidence, not an established benefit.

Who should avoid reishi mushroom?

People taking blood thinners, blood pressure medication, diabetes medication, or immunosuppressants; people with liver disease; people scheduled for surgery; and pregnant or breastfeeding individuals should speak with a qualified clinician before using reishi, since it may interact with these conditions and medications.

Educational Disclaimer

This article provides general educational information and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Evidence for reishi mushroom varies by preparation, dose, and population studied, and much of the research described here comes from small or preclinical studies. Ask a qualified clinician before starting, stopping, or changing any supplement or medication, particularly if you are pregnant, breastfeeding, managing a health condition, or taking prescription medication.